NCT05870007View on ClinicalTrials.gov

Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Autosomal Dominant Polycystic Kidney DiseaseChronic Kidney Diseases
Interventions
DRUG

Atorvastatin 20 Mg Oral Tablet

Atorvastatin 20mg

DRUG

Sodium Bicarbonate 600 Mg Oral Tablet

Sodium bicarbonate would be titrated up to 1800mg per day according to metabolic acidosis severity during clinical follow-up

Trial Locations (3)

235

Shuang Ho Hospital, New Taipei City

Unknown

Taipei Medical University Hospital, Taipei

Wan Fang Hospital, Taipei

All Listed Sponsors
collaborator

University of Southern California

OTHER

lead

Taipei Medical University Shuang Ho Hospital

OTHER